| Old Articles: <Older 25221-25230 Newer> |
 |
The Motley Fool August 6, 2007 Tom Taulli |
High Times at Taleo The little-known on-demand software company is finally getting on investors' radar.  |
The Motley Fool August 6, 2007 Brian Lawler |
Don't Discount ViroPharma The exciting biopharma announces its second-quarter financial results. Considering that its lead drug is highly profitable and has two strong pipeline candidates in development, shares of ViroPharma don't look expensive.  |
The Motley Fool August 6, 2007 Brian Lawler |
Unhappy Delays for MannKind Two delays for the inhalable insulin developer cause the stock to drop.  |
The Motley Fool August 6, 2007 Lawrence Rothman |
Timberland's Uphill Battle Timberland hopes to change its footprint. While the third quarter is expected to remain weak, cost cutting should help offset top-line weakness in the fourth quarter.  |
The Motley Fool August 6, 2007 Lawrence Rothman |
Playtex Gets Charged Up Even after a buyout by Energizer, Playtex keeps turning in solid quarters. Investors, take note.  |
The Motley Fool August 6, 2007 Tom Taulli |
Sourcefire Being Reduced to Ashes? The security company's prospects remain murky. And with investors shell-shocked from recent stock price drops, it's not easy to make a bull case.  |
The Motley Fool August 6, 2007 Dave Mock |
Foolish Forecast: How Now, Sprint Nextel? The wireless services provider will call in to report second-quarter earnings shortly. Investors, here is what you can expect to see.  |
The Motley Fool August 6, 2007 Brian Orelli |
Congress' Delay May Hurt Drugmakers The reauthorization of the Prescription Drug User Fee Act is delayed. If you're an investor in drug companies, now might be a good time to call your representatives and senators.  |
The Motley Fool August 6, 2007 Dave Mock |
Foolish Forecast: A Steady Line for InterDigital? The wireless firm is set to deliver its second-quarter earnings shortly. Investors, here is what you can expect to see.  |
The Motley Fool August 6, 2007 Rich Duprey |
Foolish Forecast: SAM I Am Boston Beer will report second-quarter financial results shortly. Investors, here is what you can expect to see.  |
| <Older 25221-25230 Newer> Return to current articles. |